KSD-101 Therapy for EBV-associated Haematologic Neoplasms: an Exploratory Clinical Trial
KSD-101 Therapy for EBV-associated Haematologic Neoplasms: an Exploratory Clinical Trial
Enrolling by invitation · NCT05635591 · Registry updated 2026-04-08Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| KSD-101 Therapy for EBV-associated Haematologic Neoplasms: an Exploratory Clinical Trial | EBV-associated Haematologic Neoplasms | Enrolling by invitation | Phase 1 | 2026-04-08 | NCT05635591 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Kousai Bio Co., Ltd. | 4 |
| Tongji Hospital | 276 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Li Chunrui | Wuhan | China | 1 |